Skip to main content

Table 4 T cell responses to CEF and MVA antigens by IFN-γ ELISPOT

From: Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

Patient Number

Antigen

Peak Ag Specific T cell Precursor Frequencies

  

Pre

Post

1

CEF

ND

1/1,299

 

MVA

ND

1/11,364

2

CEF

ND

1/10,929

 

MVA

ND

1/4,926

3

CEF

ND

ND

 

MVA

1/18,182

1/10,341

5

CEF

ND

1/1,658

 

MVA

ND

1/3,993

6

CEF

< 1/200,000

< 1/200,000

 

MVA

1/4,411

1/2,629

7

CEF

ND

1/2,084

 

MVA

ND

1/1,935

8

CEF

1/1,613

1/1,126

 

MVA

< 1/200,000

1/1770

9

CEF

1/1,040

1/956

 

MVA

1/5,263

1/1,452

10

CEF

< 1/200,000

< 1/200,000

 

MVA

< 1/200,000

1/3,442

11

CEF

1/5,882

1/2,362

 

MVA

1/3,030

1/2,135

12

CEF

ND

< 1/200,000

 

MVA

< 1/200,000

1/45455

13

CEF

< 1/200,000

< 1/200,000

 

MVA

< 1/200,000

1/29,630

14

CEF

1/631

1/619

 

MVA

1/928

1/2,112

15

CEF

1/1,357

1/1,445

 

MVA

1/3,731

1/2,901

16

CEF

1/2,070

1/2,316

 

MVA

1/2,618

1/2,685

17

CEF

ND

1/10,216

 

MVA

ND

1/5,405

19

CEF

1/1,543

1/2,335

 

MVA

1/5,618

1/2,273

20

CEF

< 1/200,000

< 1/200,000

 

MVA

1/868

1/984

21

CEF

< 1/200,000

< 1/200,000

 

MVA

1/1,230

1/945

22

CEF

ND

1/1,789

 

MVA

ND

1/1,988

23

CEF

1/629

1/1,056

 

MVA

1/5,208

1/4,561

24

CEF

1/870

1/1,078

 

MVA

1/1,923

1/23,256

25

CEF

1/1,538

1/1,161

 

MVA

1/7,143

1/3,697

  1. Abbreviation: ND, not detected